X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MARKSANS PHARMA. Share Price   (TCPH)

Here is the latest stock price and chart of MARKSANS PHARMA.. For a sector overview, read our pharmaceuticals sector report.

REFRESH
Live BSE Quotes Apr 27, 2018 10:13:00 AM
Price (Rs)33.45 Open (Rs) 33.20 High (Rs) 33.85 Low (Rs) 33.20
% Change0.15 Volume 25,013 Value (Rs) 836,685 52-Week H/L 56.25 / 31.00
Live NSE Quotes Apr 27, 2018 10:14:59 AM
Price (Rs)33.45 Open (Rs) 33.40 High (Rs) 33.85 Low (Rs) 33.35
% Change0.15 Volume 284,746 Value (Rs) 9,567,466 52-Week H/L 56.30 / 31.00
  BSE Sensex | CNX Nifty


MARKSANS PHARMA. Share Price Today:

MARKSANS PHARMA. share price is up 0.1% to Rs 33.5 on the BSE. On the NSE, the MARKSANS PHARMA. share price is up 0.1% to Rs 33.5. The total volume of shares traded is 0.3 m.

Overall, the broader S&P BSE HEALTHCARE Index is trading up by 0.5%. And the benchmark S&P BSE SENSEX is at 35,017.1 (up 0.9%).

Over the last 30 days, the MARKSANS PHARMA. share price is up 6.2%. And over the last one year, MARKSANS PHARMA. share price is down 35.1%.





Today's Market

Sensex Opens 217 Points Up; Axis Bank & Yes Bank Top Gainers(09:30 am)

Asian stock markets are higher today as Japanese and Hong Kong shares show gains. The Nikkei 225 is up 0.4% while the Hang Seng is up 0.2%. Meanwhile, the Shanghai Composite is trading down by 0.6%.

Related Views On News

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

More Views on News

Most Popular

Why India is Short of Cash Again(Vivek Kaul's Diary)

Apr 19, 2018

It is basically a supply problem with not enough currency going around in the financial system.

A Sure Shot Way to Predict a Multibagger Stock(The 5 Minute Wrapup)

Apr 17, 2018

The imaginary stock price of IIM Ahmedabad could have rivalled the returns from Titan and Asian Paints thanks to its enormous pricing power.

Why Buffett Would Scowl at My Latest Recommendation...(Profit Hunter)

Apr 18, 2018

Warren Buffett's advice that may not be so relevant in these dynamic times, and could do investors more damage than good when taken at the face value.

This is How a Smart Robo-Advisor can Help You Chart Your Asset Allocation...(Outside View)

Apr 16, 2018

PersonalFN explains how a dependable robo-advisory platform can help you create your personalized asset allocation plan

How Retail Investors Often Dump the Best Buying Opportunities(Chart Of The Day)

Apr 16, 2018

A journey into how retail investors have invested since the turn of the millennium and why I don't want to do repeat that mistake ever again...

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK MARKSANS PHARMA.

  • Track your investment in MARKSANS PHARMA. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MARKET STATS